View in EDS

FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.

Saved in:
Bibliographic Details
Title: FDA Public Workshop Summary—Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs.
Authors: O'Shaughnessy, Elizabeth1, Yasinskaya, Yuliya1, Dixon, Cheryl2, Higgins, Karen2, Moore, Jason3, Reynolds, Kellie3, Ampel, Neil M4, Angulo, David5, Blair, Janis E6, Catanzaro, Antonino7, Galgiani, John N4, Garvey, Edward8, Johnson, Royce9, Larwood, David J10, Lewis, Gareth11, Purdie, Rob9, Rex, John H12, Shubitz, Lisa F4, Stevens, David A13, Page, Stephen J14
Source: Clinical Infectious Diseases. Jun2022, Vol. 74 Issue 11, p2061-2066. 6p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/ciab904